168 related articles for article (PubMed ID: 867235)
1. [Use of xanthinol nicotinate in patients with chronic ischemic heart disease].
Sivkov II; Kukes VG; Borisov VG; Rudakov MA; Blistanova LS
Ter Arkh; 1977; 49(1):30-3. PubMed ID: 867235
[No Abstract] [Full Text] [Related]
2. [Therapeutic effect of complamine in atherosclerosis and ischemic heart disease].
Kalmykova VI; Aronchuk EK
Sov Med; 1976 Jan; (1):113-8. PubMed ID: 1273633
[No Abstract] [Full Text] [Related]
3. [Use of komplamin in chronic ischemic heart disease].
Serkova VK; Mikunis RI
Vrach Delo; 1984 Nov; (11):16-8. PubMed ID: 6528554
[No Abstract] [Full Text] [Related]
4. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
[No Abstract] [Full Text] [Related]
5. [Effect of complamine on various indicators of hemostasis and microcirculation in chronic ischemic heart disease].
Bol'shakova RM; Dukhina MA; Furkalo NK; Solovtsova KM; Progonnaia VV
Vrach Delo; 1978 Jan; (1):36-40. PubMed ID: 625941
[No Abstract] [Full Text] [Related]
6. [Rehabilitation course in patients with peripheral and coronary angio-organopathies. Studies with special reference to serum uric acid and cholesterol under xanthinol nicotinate].
Mensen H
Ther Ggw; 1977 Oct; 116(10):1853-81. PubMed ID: 918880
[No Abstract] [Full Text] [Related]
7. [Treatment of ischemic heart disease with complamine].
Kuz'ko NV
Vrach Delo; 1981 Jan; (1):82-4. PubMed ID: 7010784
[No Abstract] [Full Text] [Related]
8. [Ergometric evaluation of treatment of ischemic heart disease with xavine].
Zadionchenko VS; Vertkin AL; Martynov AI; Panchenkova LA; Troshina EV
Sov Med; 1978 Jan; (1):68-73. PubMed ID: 635674
[No Abstract] [Full Text] [Related]
9. Thermographical follow-up during treatment of chronic ulcerations with iontophoresis with xanthinol nicotinate.
van der Kuy A; Aarts NJ
Bibl Radiol; 1975; (6):203-9. PubMed ID: 1180851
[No Abstract] [Full Text] [Related]
10. [Pharmacological properties and clinical use of xanthinol nicotinate].
Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV
Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742
[No Abstract] [Full Text] [Related]
11. [Results of a long-term study on the therapeutic effectiveness of xanthinol nicotinate in chronic hepatopathies].
Dohrmann RE; Kessel ME
Z Allgemeinmed; 1975 Sep; (26):1167-72. PubMed ID: 1226797
[No Abstract] [Full Text] [Related]
12. [Clinical trial of xanthinol nicotinate in delayed form in the treatment of arteritis of the lower limbs].
Niquet G; Dupont T
Lille Med; 1976 Jan; 21(1 suppl 1):13-5. PubMed ID: 1256225
[No Abstract] [Full Text] [Related]
13. Acute effect of xanthinol nicotinate on the muscle clearance of 133Xenon.
Szilvási I; Molnár G
Ther Hung; 1973; 21(3-4):114-6. PubMed ID: 4806418
[No Abstract] [Full Text] [Related]
14. [Treatment of chronic arterial vascular disorders with Complamin and Complamin retard].
Musil HE
Med Welt; 1973 Jan; 24(3):103-13. PubMed ID: 4617835
[No Abstract] [Full Text] [Related]
15. [The effect of xanthinol nicotinate on the serum lipids and lipoproteins of patients with primary hyperlipoproteinemia Type IIb and IV].
Haacke H; Parwaresch MR; Mäder C
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():829-32. PubMed ID: 1029294
[No Abstract] [Full Text] [Related]
16. [Drug therapy of hyperlipemia. Experiences with xanthinol nicotinate retard-capsules in a general practice].
Klimm HD
Med Monatsschr; 1976 Apr; 30(4):178-80. PubMed ID: 958145
[No Abstract] [Full Text] [Related]
17. Comparative effects of placebo and plain and slow-release tablets of xanthinol nicotinate on exercise tolerance in normal human subjects.
Sharma PL
Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):19-21. PubMed ID: 631966
[TBL] [Abstract][Full Text] [Related]
18. [Xanthinol nicotinate and bufenin hydrochloride in the treatment of gestosis].
Cretti A; Jaworski S
Ginekol Pol; 1976 Aug; 47(8):909-16. PubMed ID: 971859
[No Abstract] [Full Text] [Related]
19. Xanthinol nicotinate in peripheral vascular disease.
Davis E; Rozov H
Practitioner; 1975 Dec; 215(1290):793-8. PubMed ID: 772653
[TBL] [Abstract][Full Text] [Related]
20. [Complamin in the complex therapy of patients with chronic nonspecific prostatitis].
Iunda IF; Israilov SR
Vrach Delo; 1987 Nov; (11):64-7. PubMed ID: 3439130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
